In 2019, ROP affected 27,000 premature neonates in the US and is a leading cause of childhood blindness. Laser photocoagulation and anti-VEGF [vascular endothelial growth factor] therapy - the two ...

In 2011, the BEAT-ROP study was published in the New England Journal of Medicine. That study revealed that agents called anti-vascular endothelial growth factor (anti-VEGF) agents may also be ...

Anti-VEGF injections are commonly used to treat macular ... such as retinopathy of prematurity (ROP), to their later years, including diabetic macular edema (DME), diabetic retinopathy (DR ...